The traditional pharmaceutical development funnel is currently facing a massive overhaul as researchers move away from static, isolated chemical assays toward dynamic platforms that observe drug behavior within the bustling complexity of living human cells. This transition marks a fundamental
Ivan Kairatov is a leading figure in the biopharmaceutical industry, renowned for his ability to translate complex molecular research into actionable technological innovations. With an extensive background in research and development, Kairatov has closely followed the evolution of protein
The relentless pursuit of a cancer treatment that spares the patient while obliterating the tumor has led researchers to an architectural marvel smaller than a speck of dust. Modern oncology faces a persistent paradox where the very drugs designed to save lives often cause profound systemic damage
The relentless pursuit of miniaturization in the semiconductor industry has reached a pivotal threshold where traditional silicon transistors struggle to maintain performance due to tunneling effects and thermal leakage. As global demand for high-performance computing and energy-efficient mobile
The ability to monitor the precise journey of therapeutic cells within the human body has remained an elusive goal for decades, often forcing clinicians to rely on indirect markers to guess whether a treatment has reached its intended target. This lack of visibility represents a significant hurdle
The quest to replicate the intricate machinery of biological life has moved beyond mere observation into the realm of precision engineering with the development of synthetic cell microreactors. Researchers at the University of Stuttgart have successfully demonstrated a "double-necked" platform that
